Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Pantheon launches $4bn infrastructure secondaries fund with backing from Korean institutions
Pantheon launches $4bn infrastructure secondaries fund with backing from Korean institutions Pantheon has begun raising $4bn for its latest infrastructure secondaries vehicle, the Pantheon Global Infrastructure Fund (PGIF) V, with commitments expected from leading...
Karo Healthcare to acquire Perrigo’s €120m skin health portfolio after KKR takeover
Karo Healthcare to acquire Perrigo’s €120m skin health portfolio after KKR takeover Karo Healthcare has confirmed the acquisition of Perrigo’s Dermacosmetics portfolio of skin health brands, following the completion of its takeover by KKR. The deal, which is expected...
Apollo unveils $5bn playbook for sports investments amid private equity boom
Apollo unveils $5bn playbook for sports investments amid private equity boom Apollo Global Management is preparing to launch a $5bn sports investment vehicle as it accelerates its push into the fast-growing sports finance sector, according to the Financial Times. The...